Royalty Report: Medical, Device, Diagnostic – Collection: 118427

$100.00

Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 3

Description

This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 3

Primary Industries

  • Medical
  • Device
  • Diagnostic
  • Disease
  • Imaging
  • Scientific & Technical Instruments

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 118427

License Grant
Licensor of Germany grants the Company exclusive distribution rights for all devices currently produced by Licensor. The distribution rights are worldwide, except that Germany is currently excluded.  The pDEXA was developed jointly by the Company and Licensor. The Licensor Distribution Agreement gives the Company the right to manufacture pDEXA systems to be sold in North America and Latin America, while Licensor has the right to manufacture the pDEXA for sale outside North America and Latin America. The Company has the right to purchase from Licensor components and parts (other than computer components) used to manufacture the pDEXA. It may also purchase  such components and parts from other sources. The Company is also the exclusive manufacturer of all pQCT systems (other than research systems) to be sold in North America, and the Company purchases components and parts (other than computer components) for such systems from Licensor.
License Property
pQCT systems permit separate, three-dimensional measurement of cortical and trabecular bone by taking multiple images in a 360-degree rotation around the scanned limb,  providing true volumetric density and allowing more precise assessment of biomechanical soundness of the bone. The ability to measure trabecular bone precisely also permits detection over short periods of time of minute changes in bone, indicating changes in metabolic status. The pQCT systems use the same miniaturized low-radiation X-ray source as the pDEXA. The pQCT-based XCT2000 scans the forearm and is marketed to hospitals, including pediatric care hospitals that require a device capable of measuring changes in smaller bones, clinics and private practices. The pQCT-based XCT3000 can also scan the tibia, the femur and is capable of three-dimensional measurement of the entire femoral neck, providing more precise assessment of hip fractures and monitoring of implants following hip replacements.  Used in disorders, particularly osteoporosis.  Osteoporosis progresses as a symptomless disease characterized by bone loss and deterioration of the skeleton, leading to bone fragility and increased risk of fracture.
Field of Use
pQCT is a bone densitometry system based on peripheral quantitative computed tomography.

This agreement pertains to the medical industry relating to a wide range of bone densitometers used to assess bone mineral content and density, one of several factors used by physicians to aid in the diagnosis and monitoring of bone disorders, particularly osteoporosis.

IPSCIO Record ID: 27454

License Grant
LICENSOR hereby grants to LICENSEE an exclusive, worldwide license to use and sell LICENSED PRODUCTS but solely for application within the FIELD OF USE.
License Property
Osteopatch, a transdermal perspiration collection device, is patented skin patch product that measures bone loss markers in human perspiration.

The Osteopatch (Trademark) is designed for extended wear (e.g. several days) and is particularly useful in capturing biochemical markers via continuous collection from perspiration over an extended time period.

The term 'OSTEOPOROSIS' shall have its ordinary medical meaning, namely the abnormal decrease in density, but not volume, of bone.

The LICENSED PATENTS include, but are not limited to, United States Patents Nos. 4,957,108, 5,076,273, and any patents issuing on United States Patent Applications Serial Nos. 07/569,007, 07/929,628.

Field of Use
The term 'FIELD OF USE' shall mean detecting and/or measuring biochemical markers pyridinoline and deoxypyridoline, but only for the purposes of diagnosing bone loss which leads to osteoporosis and of monitoring preventive care and treatment of osteoporosis. It is recognized and understood by both parties that it may also be necessary to measure certain hormones and other substances in order to calibrate and/or quantify the biochemical markers listed above. In addition, 'FIELD OF USE' shall include the detection and/or measurements of other biochemical markers and substances that may in the future offer a superior method of diagnosing bone loss leading to osteoporosis and therapy.

Osteopatch is a skin patch for potential use in managing osteoporosis and related diseases.

IPSCIO Record ID: 26371

License Grant
The Company entered into an Exclusive License Agreement and a Sponsored Research Agreement in connection with the development of its second-generation OsteoSystem; worldwide rights, in the field of bone densitometry; patents claiming an invention in the field of quantitative radiographic imaging.
License Property
U.S. Patents No. 5,465,284 and 5,150,394 entitled System for Quantitative Radiographic Imaging
Field of Use
Field shall mean the area of bone densitometry.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.